AI Predicts Which Keratoconus Patients Need treatment
Table of Contents
Researchers have successfully used artificial intelligence (AI) to predict which patients need treatment to stabilise their corneas and preserve their eyesight, in a study presented today (Sunday) at teh 43rd Congress of the European Society of Cataract and Refractive surgeons (ESCRS). [1]
Understanding Keratoconus
The research focused on people wiht keratoconus, a visual impairment that generally develops in teenagers and young adults and tends to worsen into adulthood. It affects up to 1 in 350 people. In certain specific cases, the condition can be managed with contact lenses, but in others it deteriorates quickly. Without treatment, patients may eventually require a corneal transplant. Currently, determining who needs immediate intervention relies on monitoring patients over time.
How AI is Changing the game
Researchers utilized AI to analyze images of patients’ eyes, alongside other relevant data, and accurately predict which patients required prompt treatment versus those who could safely continue with regular monitoring. This represents a important step forward in personalized eye care.
The Research Team and Findings
The study was conducted by Dr. Shafi Balal and colleagues at Moorfields Eye Hospital NHS Foundation Trust, London, and university college London (UCL), UK. Dr. Balal explained: “In people with keratoconus, the cornea – the eye’s front window – bulges outwards. keratoconus causes visual impairment in young, working-age patients and is the most common reason for corneal transplantation in the Western world.
“A single treatment – corneal crosslinking – can halt the progression of the condition, but it’s not suitable for everyone. Currently, doctors monitor patients to see if their condition is worsening before offering treatment. This can mean that some patients wait too long and their vision deteriorates unnecessarily.”
AI’s Predictive Power
The AI model demonstrated a high degree of accuracy in identifying patients likely to benefit from corneal crosslinking. This allows clinicians to proactively intervene,potentially preventing further vision loss and reducing the need for more invasive procedures like transplants.
Implications and Future Directions
This research highlights the potential of AI to revolutionize the management of keratoconus and other corneal diseases. By enabling earlier and more targeted treatment, AI can improve patient outcomes and quality of life. Further research will focus on refining the AI model and expanding it’s submission to other eye conditions.
Key Takeaways
- AI can accurately predict which keratoconus patients need treatment.
- Early intervention with corneal crosslinking can halt disease progression.
- This technology has the potential to reduce the need for corneal transplants.
- The research was conducted by experts at moorfields Eye Hospital and UCL.
Source: [1] ESCRS News
Related reading